Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析

◆英語タイトル:Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15290
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Core Laboratories NV (CLB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Core Laboratories NV (Core Lab) is an oil and gas service provider. It offers patented and proprietary reservoir description and reservoir management services. Its portfolio includes core analysis, reservoir fluid analysis, inspection, testing & calibration, instruments, integrated reservoir solutions and others to major national and independent oil companies. The company also provides laboratory equipment to client company research labs, universities and government institutes. Core Lab’s patented technologies include SpectraChem, SpectraFlood, SMAX, PACKSCAN, SuperHERO, SuperHERO Plus, X-SPAN, ZERO WASH and GTX-SPAN among others. The company has operational presence in countires including the US, Canada and others globally. Core Lab is headquartered in Amsterdam, the Netherlands.

Core Laboratories NV Key Recent Developments

Jan 30,2019: Core Lab reports fourth quarter 2018 results from continuing operations
Jul 25,2018: Core Lab reports second quarter 2018 results from continuing operations
Jul 02,2018: New Target in Certain Leukemias Found, Could Be Treated With Existing Drug
Apr 25,2018: Core Lab Reports First Quarter 2018 Results From Continuing Operations
Jan 31,2018: Core Lab Reports Fourth Quarter 2017 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Core Laboratories NV – Key Facts
Core Laboratories NV – Key Employees
Core Laboratories NV – Key Employee Biographies
Core Laboratories NV – Major Products and Services
Core Laboratories NV – History
Core Laboratories NV – Company Statement
Core Laboratories NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Core Laboratories NV – Business Description
Business Segment: Production Enhancement
Overview
Performance
Business Segment: Reservoir Description
Overview
Performance
Core Laboratories NV – Corporate Strategy
Core Laboratories NV – SWOT Analysis
SWOT Analysis – Overview
Core Laboratories NV – Strengths
Core Laboratories NV – Weaknesses
Core Laboratories NV – Opportunities
Core Laboratories NV – Threats
Core Laboratories NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s, Oil & Gas Financial Deals and Alliances
Core Laboratories NV, Oil & Gas, Deals By Year, 2013 to YTD 2019
Core Laboratories NV, Oil & Gas, Deals By Type, 2013 to YTD 2019
Core Laboratories NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 30, 2019: Core Lab reports fourth quarter 2018 results from continuing operations
Jul 25, 2018: Core Lab reports second quarter 2018 results from continuing operations
Jul 02, 2018: New Target in Certain Leukemias Found, Could Be Treated With Existing Drug
Apr 25, 2018: Core Lab Reports First Quarter 2018 Results From Continuing Operations
Jan 31, 2018: Core Lab Reports Fourth Quarter 2017 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Core Laboratories NV, Key Facts
Core Laboratories NV, Key Employees
Core Laboratories NV, Key Employee Biographies
Core Laboratories NV, Major Products and Services
Core Laboratories NV, History
Core Laboratories NV, Subsidiaries
Core Laboratories NV, Key Competitors
Core Laboratories NV, Ratios based on current share price
Core Laboratories NV, Annual Ratios
Core Laboratories NV, Annual Ratios (Cont...1)
Core Laboratories NV, Annual Ratios (Cont...2)
Core Laboratories NV, Interim Ratios
Core Laboratories NV, Oil & Gas, Deals By Year, 2013 to YTD 2019
Core Laboratories NV, Oil & Gas, Deals By Type, 2013 to YTD 2019
Core Laboratories NV, Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Core Laboratories NV, Performance Chart (2014 - 2018)
Core Laboratories NV, Ratio Charts
Core Laboratories NV, Oil & Gas, Deals By Year, 2013 to YTD 2019
Core Laboratories NV, Oil & Gas, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corvel Corporation:企業の戦略・SWOT・財務分析
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PIK-Group:企業のM&A・事業提携・投資動向
    PIK-Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PIK-Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Terumo Corp (4543):企業の財務・戦略的SWOT分析
    Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aclaris Therapeutics Inc (ACRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aclaris Therapeutics Inc (Aclaris Therapeutics) is a dermatologist-led bio-pharmaceutical company which focuses on identifying, developing, and commercializing prescription drug products for unmet needs in aesthetic and medical dermatology as well as immunology. Its lead product, ESKATA, is …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SNC-Lavalin Group Inc.:企業のM&A・事業提携・投資動向
    SNC-Lavalin Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SNC-Lavalin Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Bunge Ltd (BG):企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Nanovis Inc-医療機器分野:企業M&A・提携分析
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company provides products such as implant nanosurfaces, implantable scaffolds and cervical plate, among others. Nanovis offers products PEEK interbody syste …
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a brand of MKS Instruments Equipment & Solutions Division, which offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, mem …
  • KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of reco …
  • Woodward Inc:企業の戦略・SWOT・財務情報
    Woodward Inc - Strategy, SWOT and Corporate Finance Report Summary Woodward Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Alinma Bank:企業の戦略・SWOT・財務分析
    Alinma Bank - Strategy, SWOT and Corporate Finance Report Summary Alinma Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bio-Alternative Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Bio-Alternative Medical Devices Ltd (Bio AMD), a subsidiary of Bio-AMD Inc, is a medical device company that designs, develops, and markets point of care medical diagnostic products. The company offers products such as blood coagulation monitor, digital strip reader, and magnetic immunoassay …
  • Aurora Health Care Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care. The organization offers its healthcare services to communities throughout eastern Wisconsin and northern Illinois. Its service offerings include primary and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆